Free CME from PeerView


Allergy & Immunology CME

Credits: 0.50 CME / MOC - ABO
Medical Learning Institute, Inc.
A Quick Look at Recent Evidence for Improving Outcomes in Patients With Diabetic Retinopathy Using Anti-VEGF Therapy
February 25, 2021
Corey Cutler, MD, MPH, FRCP(C) / Miguel-Angel Perales, MD
The Medical College of Wisconsin
New Perspectives in Acute and Chronic GVHD: Challenges and Opportunities for Improving Prophylaxis and Treatment With Novel Therapeutics
February 23, 2021
The Medical College of Wisconsin
The Multiple Myeloma Workshop: Exploring the Convergence of Novel Therapeutic Platforms, Cell Therapy, and ASCT
February 17, 2021
Anne H. Cross, MD, FAAN / Prof. Xavier Montalban
Medical Learning Institute, Inc.
Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis
February 01, 2021
Maria K. Houtchens, MD, MMs
Medical Learning Institute, Inc.
MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies
January 22, 2021
Medical Learning Institute, Inc.
Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
December 31, 2020
Medical Learning Institute, Inc.
Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies
December 31, 2020
Medical Learning Institute, Inc.
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
December 30, 2020
Medical Learning Institute, Inc.
Targeting Ocular Toxicity in Multiple Myeloma: Opportunities for Ophthalmology-Oncology Collaboration
December 29, 2020

Pages